Mylan Inc. today announced that its subsidiary, Mylan Pharmaceuticals Inc., received tentative approval from the U.S. FDA for its Abbreviated New Drug Application for Venlafaxine Hydrochloride (HCl) Extended-release (ER) Capsules, 37.5 mg (base), 75 mg (base) and 150 mg (base).
The details can be read here.
Monday, November 17, 2008
Mylan Receives Tentative FDA Approval for the Generic Version of the Antidepressant Effexor XR
Posted by Amit at 6:53 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment